Variable | n | pCR(%) | P value |
---|---|---|---|
Age (year) | 0.669 | ||
≤17 | 56 | 22(39.3) | |
>17 | 40 | 14(35.0) | |
Sex | 0.111 | ||
Male | 54 | 24(44.4) | |
Female | 42 | 12(28.6) | |
Tumor location | 0.896 | ||
Tibia | 40 | 16(40.0) | |
Femur | 44 | 16(36.4) | |
Others | 12 | 4(33.3) | |
Tumor size (cm3) | 0.034 | ||
≤ 195.37 | 38 | 20(52.6) | |
> 195.37 | 58 | 18(31.0) | |
Enneking stage | 0.023 | ||
I | 28 | 15(53.6) | |
II | 46 | 16(34.8) | |
III | 22 | 5(22.7) | |
Subtype | 0.263 | ||
Osteoblastic | 58 | 23(39.7) | |
Chondroblastic | 22 | 6(27.3) | |
Others | 16 | 7(43.8) | |
Regimens of NACT | 0.261 | ||
AP | 36 | 12(33.3) | |
MAP | 60 | 24(40.0) | |
ALP | 0.342 | ||
Elevated | 50 | 21(42.0) | |
Normal | 46 | 15(32.6) | |
ESR | 0.406 | ||
Elevated | 70 | 28(40.0) | |
Normal | 26 | 8(30.8) | |
CRP | 0.592 | ||
Elevated | 64 | 25(39.1) | |
Normal | 32 | 11(34.4) | |
NLR | 0.021 | ||
LNLR | 50 | 22(44.0) | |
HNLR | 46 | 14(30.4) | |
PLR | 0.031 | ||
LPLR | 30 | 16(53.3) | |
HPLR | 66 | 20(30.3) |